Celltrion’s Remsima SC Ready For Early 2020 Launch
Formal EU Approval Received For ‘Biobetter’ Subcutaneous Infliximab
• By David Wallace
Everything is falling into place for Celltrion’s subcutaneous infliximab launch in early 2020 • Source: Shutterstock 
